Clinical applications of urinary organic acids. Part 2. Dysbiosis markers

Alternative Medicine Review

Volumn 13, Issue 4, 2008, Pages 292-306

  Lord, Richard S ^a   Bralley, J Alexander ^a,b  

^a Metametrix Institute   (United States)

^b Metametrix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLPROPIONATE; AMINO ACID; ANTIBIOTIC AGENT; ARABINITOL; BENZOIC ACID; BIOLOGICAL MARKER; CARBOHYDRATE; CARBOXYLIC ACID; CRESOL; HIPPURIC ACID; HYDROXYBENZOIC ACID; HYDROXYPHENYLPROPIONATE; INDICAN; LACTIC ACID; MANDELIC ACID; PHENOL DERIVATIVE; PHENYLACETIC ACID; PHENYLPROPIONIC ACID DERIVATIVE; POLYPHENOL; PROPIONIC ACID DERIVATIVE; TRICARBALLYLLATE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

BACTERIAL METABOLISM; DETOXIFICATION; DIAGNOSTIC PROCEDURE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIAL GROWTH; MICROBIAL METABOLISM; MICROBIAL POPULATION DYNAMICS; MICROORGANISM; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; URINALYSIS; URINARY EXCRETION;

ACIDS, CARBOCYCLIC; ANIMALS; BACTERIA; BIOLOGICAL MARKERS; CRESOLS; DIETARY CARBOHYDRATES; HUMANS; INTESTINES; PHENYLACETATES; TRYPTOPHAN; YEASTS;

EID: 58749084167     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Rechner AR, Smith MA, Kuhnle G, et al. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 2004;36:212-225.
2. Lord RS, Bralley JA. Laboratory Evaluations for Integrative and Functional Medicine. Duluth, GA: Metametrix Institute; 2008.
3. Child MW, Kennedy A, Walker AW, et al. Studies on the effect of system retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques. FEMS Microbiol Ecol 2006;55:299-310.
4. van der Heiden C, Wauters EA, Duran M, et al. Gas chromatographic analysis of urinary tyrosine and phenylalanine metabolites in patients with gastrointestinal disorders. Clin Chim Acta 1971;34:289-296.
5. Goodwin BL, Ruthven CR, Sandler M. Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem Pharmacol 1994;47:2294-2297.
6. Scalbert A, Morand C, Manach C, Remesy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 2002;56:276-282.
7. Gonthier MP, Verny MA, Besson C, et al. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 2003;133:1853-1859.
8. Adamson RH, Bridges JW, Evans ME, Williams RT. Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J 1970;116:437-443.
9. Mulder TP, Rietveld AG, van Amelsvoort JM. Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. Am J Clin Nutr 2005;81:256S-260S.
10. Clifford MN, Copeland EL, Bloxsidge JP, Mitchell LA. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica 2000;30:317-326.
11. Li C, Lee MJ, Sheng S, et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 2000;13:177-184.
12. de Luca C, Passi S, Quattrucci E. Simultaneous determination of sorbic acid, benzoic acid and parabens in foods: a new gas chromatography-mass spectrometry technique adopted in a survey on Italian foods and beverages. Food Addit Contam 1995;12:1-7.
13. Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part 1. Detoxification markers. Altern Med Rev 2008;13:205-215.
14. Quick A. The study of benzoic acid conjugation in the dog with a direct quantitative method for hippuric acid. J Biol Chem 1934:477-490.
15. Temellini A, Mogavero S, Giulianotti PC, et al. Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 1993;23:1427-1433.
16. Andersson R, Carlsson A, Nordqvist MB, Sollenberg J. Urinary excretion of hippuric acid and o-cresol after laboratory exposure of humans to toluene. Int Arch Occup Environ Health 1983;53:101-108.
17. Jenner AM, Rafter J, Halliwell B. Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic Biol Med 2005;38:763-772.
18. Sarkissian CN, Scriver CR, Mamer OA. Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia. Anal Biochem 2000;280:242-249.
19. Martynyuk AE, Glushakov AV, Sumners C, et al. Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab 2005;86:S34-S42.
20. Fischer GM, Nemeti B, Farkas V, et al. Metabolism of carnitine in phenylacetic acid-treated rats and in patients with phenylketonuria. Biochim Biophys Acta 2000;1501:200-210.
21. Lambert MA, Moss CW. Production of p-hydroxyhydrocinnamic acid from tyrosine by Peptostreptococcus anaerobius. J Clin Microbiol 1980;42:291-293.
22. Rinaldo P, O'Shea JJ, Welch RD, Tanaka K. The enzymatic basis for the dehydrogenation of 3-phenylpropionic acid: in vitro reaction of 3-phenylpropionyl-CoA with various acyl-CoA dehydrogenases. Pediatr Res 1990;27:501-507.
23. Bennett MJ, Bhala A, Poirier SF, et al. When do gut flora in the newborn produce 3-phenylpropionic acid? Implications for early diagnosis of medium-chain acyl-CoA dehydrogenase deficiency. Clin Chem 1992;38:278-281.
24. Bhala A, Bennett MJ, McGowan KL, Hale DE. Limitations of 3-phenylpropionylglycine in early screening for medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1993;122:100-103.
25. Martin AK, Milne JA, Moberly P. The origin of urinary aromatic compounds excreted by ruminants. 4. The potential use of urine aromatic acid and phenol outputs as a measure of voluntary food intake. Br J Nutr 1983;49:87-99.
26. Bures J, Jergeova Z, Sobotka L, et al. Excretion of phenol and p-cresol in the urine in fasting obese individuals and in persons treated with total enteral nutrition. Cas Lek Cesk 1990;129:1166-1171. [Article in Czech]
27. Martin AK. The origin of urinary aromatic compounds excreted by ruminants. 3. The metabolism of phenolic compounds to simple phenols. Br J Nutr 1982;48:497-507.
28. Tamm AO. Biochemical activity of intestinal microflora in adult coeliac disease. Nahrung 1984;28:711-715.
29. Niwa T, Ise M, Miyazaki T, Meada K. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats. Nephron 1993;65:82-87.
30. De Preter V, Vanhoutte T, Huys G, et al. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 2007;292:G358-G368.
31. Barker JL, Frost JW. Microbial synthesis of p-hydroxybenzoic acid from glucose. Biotechnol Bioeng 2001;76:376-390.
32. Zhivotnikova NV. Changes in bioenergy processes in rat liver mitochondria after exposure to diglycidyl ether of p-hydroxybenzoic acid. Gig Sanit 1990;11:20-22.
33. Ward LA, Johnson KA, Robinson IM, Yokoyama MT. Isolation from swine feces of a bacterium which decarboxylates p-hydroxyphenylacetic acid to 4-methylphenol (p-cresol). Appl Environ Microbiol 1987;53:189-192.
34. Rechner AR, Kuhnle G, Hu H, et al. The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Radic Res 2002;36:1229-1241.
35. Chalmers RA, Valman HB, Liberman MM. Measurement of 4-hydroxyphenylacetic aciduria as a screening test for small-bowel disease. Clin Chem 1979;25:1791-1794.
36. Fellaman JH, Buist NR, Kennaway NG. Pitfalls in metabolic studies: the origin of urinary p-tyramine. Clin Biochem 1977;10:168-170.
37. Van der Heiden C, Wadman SK, Ketting D, De Bree PK. Urinary and faecal excretion of metabolites of tyrosine and phenylalanine in a patient with cystic fibrosis and severely impaired amino acid absorption. Clin Chim Acta 1971;31:133-141.
38. Rios LY, Gonthier MP, Remesy C, et al. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr 2003;77:912-918.
39. Aura AM, O'Leary KA, Williamson G, et al. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J Agric Food Chem 2002;50:1725-1730.
40. Lindblad BS, Alm J, Lundsjo A, Rafter JJ. Absorption of biological amines of bacterial origin in normal and sick infants. Ciba Found Symp 1979;70:281-291.
41. Scheline RR, Midtvedt T. Absence of dehydroxylation of caffeic acid in germ-free rats. Experientia 1970;26:1068-1069.
42. Ward NC, Croft KD, Puddey IB, Hodgson JM. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem 2004;52:5545-5549.
43. Griffiths LA. Studies on flavonoid metabolism. Identification of the metabolities of (+)-catechin in rat urine. Biochem J 1964;92:173-179.
44. Khan RI, Onodera R, Amin MR, Mohammed N. Aromatic amino acid biosynthesis and production of related compounds from p-hydroxyphenylpyruvic acid by rumen bacteria, protozoa and their mixture. Amino Acids 2002;22:167-177.
45. Elsden SR, Hilton MG, Waller JM. The end products of the metabolism of aromatic amino acids by Clostridia. Arch Microbiol 1976;107:283-288.
46. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758-764.
47. Taormina PJ, Bartholomew GW, Dorsa WJ. Incidence of Clostridium perfringens in commercially produced cured raw meat product mixtures and behavior in cooked products during chilling and refrigerated storage. J Food Prot 2003;66:72-81.
48. Delgado S, Suarez A, Mayo B. Identification of dominant bacteria in feces and colonic mucosa from healthy Spanish adults by culturing and by 16S rDNA sequence analysis. Dig Dis Sci 2006;51:744-751.
49. Konishi Y, Kobayashi S. Microbial metabolites of ingested caffeic acid are absorbed by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. J Agric Food Chem 2004;52:6418-6424.
50. Schwarz G, Bauder R, Speer M, et al. Microbial metabolism of quinoline and related compounds. II. Degradation of quinoline by Pseudomonas fluorescens 3, Pseudomonasputida 86 and Rhodococcus spec. B1. Biol Chem Hoppe Seyler 1989;370:1183-1189.
51. Kim HK, Jeong TS, Lee MK, et al. Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta 2003;327:129-137.
52. Moridani MY, Scobie H, Jamshidzadeh A, et al. Caffeic acid, chlorogenic acid, and dihydrocaffeic acid metabolism: glutathione conjugate formation. Drug Metab Dispos 2001;29:1432-1439.
53. Shukla OP. Microbial transformation of quinoline by a Pseudomonas sp. Appl Environ Microbiol 1986;51:1332-1342.
54. Shukla OP. Microbiological degradation of quinoline by Pseudomonas stutzeri: the coumarin pathway of quinoline catabolism. Microbios 1989;59:47-63.
55. Bugg TD. Overproduction, purification and properties of 2,3-dihydroxyphenylpropionate 1,2-dioxygenase from Escherichia coli. Biochim Biophys Acta 1993;1202:258-264.
56. Spence EL, Kawamukai M, Sanvoisin J, et al. Catechol dioxygenases from Escherichia coli (MhpB) and Alcaligenes eutrophus (MpcI): sequence analysis and biochemical properties of a third family of extradiol dioxygenases. J Bacteriol 1996;178:5249-5256.
57. Powell-Jackson PR, Maudgal DP, Sharp D, et al. Intestinal bacterial metabolism of protein and bile acids: role in pathogenesis of hepatic disease after jejuno-ileal bypass surgery. Br J Surg 1979;66:772-775.
58. Tohyama K, Kobayashi Y, Kan T, et al. Effect of Lactobacilli on urinary indican excretion in gnotobiotic rats and in man. Microbiol Immunol 1981;25:101-112.
59. Yoshida K, Hirayama C. Tryptophan metabolism in liver cirrhosis: influence of oral antibiotics on neuropsychiatric symptoms. Tohoku J Exp Med 1984;142:35-41.
60. Miloszewski K, Kelleher J, Walker BE, et al. Increase in urinary indican excretion in pancreatic steatorrhoea following replacement therapy. Scand J Gastroenterol 1975;10:481-485.
61. Lawrie CA, Renwick AG, Sims J. The urinary excretion of bacterial amino-acid metabolites by rats fed saccharin in the diet. Food Chem Toxicol 1985;23:445-450.
62. Kirkland JL, Vargas E, Lye M. Indican excretion in the elderly. Postgrad Med J 1983;59:717-719.
63. Smith DF. Effects of age on serum tryptophan and urine indican in adults given a tryptophan load test. Eur J Drug Metab Pharmacokinet 1982;7:55-58.
64. Aarbakke J, Schjonsby H. Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome. Scand J Gastroenterol 1976;11:409-414.
65. Stachow A, Jablonska S, Skiendzielewska A. Intestinal absorption of L-tryptophan in scleroderma. Acta Derm Venereol 1976;56:257-264.
66. Mayer PJ, Beeken WL. The role of urinary indican as a predictor of bacterial colonization in the human jejunum. Am J Dig Dis 1975;20:1003-1009.
67. Patney NL, Mehrotra MP, Khanna HK, Kumar A. Urinary indican excretion in cirrhosis of liver. J Assoc Physicians India 1976;24:291-295.
68. Montgomery RD, Haeney MR, Ross IN, et al. The ageing gut: a study of intestinal absorption in relation to nutrition in the elderly. Q J Med 1978;47:197-224.
69. Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr 2005;135:1619-1625.
70. Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microb Pathog 1997;22:285-293.
71. Bongaerts G, Severijnen R, Skladal D, et al. Yeast mediates lactic acidosis suppression after antibiotic cocktail treatment in short small bowel? Scand J Gastroenterol 2005;40:1246-1250.
72. Hudson M, Pocknee R, Mowat NA. D-lactic acidosis in short bowel syndrome - an examination of possible mechanisms. Q J Med 1990;74:157-163.
73. Vella A, Farrugia G. D-lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc 1998;73:451-456.
74. Haan E, Brown G, Bankier A, et al. Severe illness caused by the products of bacterial metabolism in a child with a short gut. Eur J Pediatr 1985;144:63-65.
75. Traube M, Bock JL, Boyer JL. D-lactic acidosis after jejunoileal bypass: identification of organic anions by nuclear magnetic resonance spectroscopy. Ann Intern Med 1983;98:171-173.
76. Caldarini MI, Pons S, D'Agostino D, et al. Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production. Dig Dis Sci 1996;41:1649-1652.
77. Comments in Dig Dis Sci 1997;42:1611-1612.
78. Bongaerts G, Bakkeren J, Severijnen R, et al. Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr 2000;30:288-293.
79. Bongaerts G, Tolboom J, Naber T, et al. D-lactic acidemia and aciduria in pediatric and adult patients with short bowel syndrome. Clin Chem 1995;41:107-110.
80. Zhang DL, Jiang ZW, Jiang J, et al. D-lactic acidosis secondary to short bowel syndrome. Postgrad Med J 2003;79:110-112.
81. Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore) 1998;77:73-82.
82. Dahlquist NR, Perrault J, Callaway CW, Jones JD. D-lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc 1984;59:141-145.
83. Halverson J, Gale A, Lazarus C. D-lactic acidosis and other complications of intestinal bypass surgery. Arch Intern Med 1984;144:357-360.
84. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med 1995;122:839-842.
85. Jover R, Leon J, Palazon JM, Dominguez JR. D-lactic acidosis associated with use of medium-chain triglycerides. Lancet 1995;346:314.
86. Mason PD. Metabolic acidosis due to D-lactate. Br Med J (Clin Res Ed) 1986;292:1105-1106.
87. Thurn JR, Pierpont GL, Ludvigsen CW, Eckfeldt JH. D-lactate encephalopathy. Am J Med 1985;79:717-721.
88. Slyter LL, Rumsey TS. Effect of coliform bacteria, feed deprivation, and pH on ruminal D-lactic acid production by steer or continuous-culture microbial populations changed from forage to concentrates. J Anim Sci 1991;69:3055-3066.
89. Smith SM, Eng RH, Buccini F. Use of D-lactic acid measurements in the diagnosis of bacterial infections. J Inject Dis 1986;154:658-664.
90. Caglayan F, Cakmak M, Caglayan O, Cavusoglu T. Plasma D-lactate levels in diagnosis of appendicitis. J Invest Surg 2003;16:233-237.
91. Demircan M. Plasma D-lactate level: a useful marker to distinguish a perforated appendix from acute simple appendicitis. J Invest Surg 2004;17:173-174; discussion 175.
92. Uchida H, Yamamoto H, Kisaki Y, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004;39:634-636.
93. Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg 1994;167:575-578.
94. Halperin ML, Kamel KS. D-lactic acidosis: turning sugar into acids in the gastrointestinal tract. Kidney Int 1996;49:1-8.
95. Connolly E, Lonnerdal B. D(-)-lactic acid-producing bacteria: safe to use in infant formulas. NUTAfoods 2004;3:37-49.
96. Haschke-Becher E, Baumgartner M, Bachmann C. Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit. Clin Chim Acta 2000;298:99-109.
97. Norton D, Crow B, Bishop M, et al. High performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) assay for chiral separation of lactic acid enantiomers in urine using a teicoplanin based stationary phase. J Chromatogr B Analyt Technol Biomed Life Sci 2007;850:190-198.
98. McDevitt J, Goldman P. Effect of the intestinal flora on the urinary organic acid profile of rats ingesting a chemically simplified diet. Food Chem Toxicol 1991;29:107-113.
99. Schwartz R, Topley M, Russell JB. Effect of tricarballylic acid, a nonmetabolizable rumen fermentation product of trans-aconitic acid, on Mg, Ca and Zn utilization of rats. J Nutr 1988;118:183-188.
100. Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 1995;41:1094-1104.
101. Marklein G, Weil HP, Rommelsheim K. Laboratory diagnostic possibilities in fungus infections in intensive care patients. Anasth Intensivther Notfallmed 1989;24:172-176. [Article in German]
102. Ness MJ, Rennard SI, Vaughn WP, et al. Detection of Candida antigen in bronchoalveolar lavage fluid. Acta Cytol 1988;32:347-352.
103. Pfaller MA. Laboratory aids in the diagnosis of invasive candidiasis. Mycopathologia 1992;120:65-72.
104. Yeo SF, Zhang Y, Schafer D, et al. A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum. J Clin Microbiol 2000;38:1439-1443.
105. Kern M, Haltrich D, Nidetzky B, Kulbe KD. Induction of aldose reductase and xylitol dehydrogenase activities in Candida tenuis CBS 4435. FEMS Microbiol Lett 1997;149:31-37.
106. Wong B, Bernard EM, Gold JW, et al. The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatine ratio and relevance to the diagnosis of candidiasis. J Infect Dis 1982;146:353-359.
107. Tokunaga S, Ohkawa M, Takashima M, Hisazumi H. Clinical significance of measurement of serum D-arabinitol levels in candiduria patients. Urol Int 1992;48:195-199.
108. Christensson B, Sigmundsdottir G, Larsson L. D-arabinitol - a marker for invasive candidiasis. Med Mycol 1999;37:391-396.
109. Roboz J. Diagnosis and monitoring of disseminated candidiasis based on serum/urine D/L-arabinitol ratios. Chirality 1994;6:51-57.
110. Wells CL, Sirany MS, Blazevic DJ. Evaluation of serum arabinitol as a diagnostic test for candidiasis. J Clin Microbiol 1983;18:353-357.
111. Holak EJ, Wu J, Spruance SL. Value of serum arabinitol for the management of Candida infections in clinical practice. Mycopathologia 1986;93:99-104.
112. Lehtonen L, Rantala A, Oksman R et al. Determination of serum arabinitol levels by mass spectrometry in patients with postoperative candidiasis. Eur J Clin Microbiol Infect Dis 1993;12:330-335.
113. Bougnoux ME, Hill C, Moissenet D, et al. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol 1990;28:905-909.
114. Sigmundsdottir G, Christensson B, Bjorklund LJ, et al. Urine D-arabinitol/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants. J Clin Microbiol 2000;38:3039-3042.
115. Lord RS, Burdette CK, Bralley JA. Significance of urinary tartaric acid. Clin Chem 2005;51:672-673.
116. Gale EF. The production of amines by bacteria: the production of tyramine by Streptococcus faecalis. Biochem J 1940;34:846-852.
117. Gale EF. The production of amines by bacteria: the decarboxylation of amino-acids by strains of Bacterium coli. Biochem J 1940;34:392-413.
118. Gale EF. The oxidation of amines by bacteria. Biochem J 1942;36:64-75.
119. Gale EF. Production of amines by bacteria: the decarboxylation of amino-acids by organisms of the groups Clostridium and Proteus with an addendum by G. L. Brown, F. C. MacIntosh, and P. Bruce White. Biochem J 1941;35:66-80.
120. Gale EF. The production of amines by bacteria: the production of putrescine from 1(+)-arginine by Bacterium coli in symbiosis with Streptococcus faecalis. Biochem J 1940;34:853-857.